Drishya Kurup

820 total citations
27 papers, 524 citations indexed

About

Drishya Kurup is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Drishya Kurup has authored 27 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 10 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Drishya Kurup's work include Viral Infections and Outbreaks Research (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Rabies epidemiology and control (10 papers). Drishya Kurup is often cited by papers focused on Viral Infections and Outbreaks Research (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Rabies epidemiology and control (10 papers). Drishya Kurup collaborates with scholars based in United States, Malaysia and Portugal. Drishya Kurup's co-authors include Matthias J. Schnell, Christoph Wirblich, Reed F. Johnson, Andrea Marzi, Heinz Feldmann, Peter B. Jahrling, Holly Ramage, Lisa E. Hensley, Christopher M. Coleman and Tara S. Abraham and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Drishya Kurup

26 papers receiving 517 citations

Peers

Drishya Kurup

EPIDE

VIROL

ASZ

John G. Bernbaum United States

Devra Huey United States

Abdul S. Yunus United States

Michael Garbutt Canada

Luke S. Uebelhoer United States

Brenda Larkin United States

Michael Pfleiderer Germany

Jason Gren Canada

Lucas J. Adams United States

Joanne Hiebert Canada

John G. Bernbaum United States

Drishya Kurup

415 ×1.1

185 ×1.0

EPIDE

121 ×1.1

VIROL

83 ×1.2

115 ×1.8

ASZ

Citations per year, relative to Drishya Kurup Drishya Kurup (= 1×) peers John G. Bernbaum

Countries citing papers authored by Drishya Kurup

Since Specialization

Citations

This map shows the geographic impact of Drishya Kurup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drishya Kurup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drishya Kurup more than expected).

Fields of papers citing papers by Drishya Kurup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drishya Kurup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drishya Kurup. The network helps show where Drishya Kurup may publish in the future.

Co-authorship network of co-authors of Drishya Kurup

This figure shows the co-authorship network connecting the top 25 collaborators of Drishya Kurup. A scholar is included among the top collaborators of Drishya Kurup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drishya Kurup. Drishya Kurup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paran, Nir, Christoph Wirblich, Kimberly H. Lohmeyer, et al.. (2025). Immunogenicity and safety of a rabies-based highly pathogenic influenza A virus H5 vaccine in cattle. npj Vaccines. 10(1). 197–197.

Kurup, Drishya, et al.. (2025). Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infection. npj Parkinson s Disease. 11(1). 86–86. 1 indexed citations

Wirblich, Christoph, et al.. (2024). Toward the Development of a Pan-Lyssavirus Vaccine. Viruses. 16(7). 1107–1107. 2 indexed citations

Kurup, Drishya, Nicole Josleyn, Eric R. Wilkinson, et al.. (2024). Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. npj Vaccines. 9(1). 143–143. 9 indexed citations

Kurup, Drishya, et al.. (2023). Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. npj Vaccines. 8(1). 10–10. 4 indexed citations

Ndeupen, Sonia, Aurélie Bouteau, Zhen Qin, et al.. (2022). Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses. PLoS Pathogens. 18(1). e1010255–e1010255. 24 indexed citations

Wirblich, Christoph, et al.. (2022). Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity. npj Vaccines. 7(1). 110–110. 10 indexed citations

Kurup, Drishya, et al.. (2022). Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract. npj Vaccines. 7(1). 43–43. 15 indexed citations

Kurup, Drishya, et al.. (2022). Current vaccine strategies against SARS-CoV-2: Promises and challenges. Journal of Allergy and Clinical Immunology. 150(1). 17–21. 8 indexed citations

10.

Kurup, Drishya & Matthias J. Schnell. (2021). SARS-CoV-2 vaccines — the biggest medical research project of the 21st century. Current Opinion in Virology. 49. 52–57. 8 indexed citations

11.

Kurup, Drishya, Delphine C. Malherbe, Christoph Wirblich, et al.. (2021). Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. PLoS Pathogens. 17(3). e1009383–e1009383. 23 indexed citations

12.

Malherbe, Delphine C., Drishya Kurup, Christoph Wirblich, et al.. (2021). A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19. npj Vaccines. 6(1). 91–91. 17 indexed citations

13.

Kurup, Drishya, Christine R. Fisher, Melissa Ferguson, et al.. (2021). Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates. The Journal of Infectious Diseases. 224(6). 995–1004. 14 indexed citations

14.

Kurup, Drishya, Christoph Wirblich, Holly Ramage, & Matthias J. Schnell. (2020). Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2. npj Vaccines. 5(1). 98–98. 31 indexed citations

15.

Postnikova, Elena, et al.. (2019). Rabies-based vaccine induces potent immune responses against Nipah virus. npj Vaccines. 4(1). 15–15. 38 indexed citations

16.

Li, Jinghe, et al.. (2017). Daxx plays a novel role in T cell survival but is dispensable in Fas-induced apoptosis. PLoS ONE. 12(3). e0174011–e0174011. 6 indexed citations

17.

Walsh, Peter D., et al.. (2017). The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?. Scientific Reports. 7(1). 43339–43339. 19 indexed citations

18.

Kurup, Drishya, et al.. (2015). Responding to the Potential of Ebola Virus Disease (EVD) Importation into Malaysia.. PubMed Central. 21(6). 3–8. 9 indexed citations

19.

Kurup, Drishya, Amy B. Papaneri, Christoph Wirblich, et al.. (2015). Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses. The Journal of Infectious Diseases. 212(suppl 2). S414–S424. 43 indexed citations

20.

Sinniah, M, et al.. (2004). Five‐year surveillance of acute flaccid paralysis in Malaysia. Journal of Paediatrics and Child Health. 40(3). 127–130. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact